E9Q Stock Overview
An investment holding company, primarily operates private hospitals in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Guangdong Kanghua Healthcare Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.23 |
| 52 Week High | HK$0.30 |
| 52 Week Low | HK$0.11 |
| Beta | 0.59 |
| 11 Month Change | -10.94% |
| 3 Month Change | -5.79% |
| 1 Year Change | 6.54% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -1.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| E9Q | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -12.3% | 4.1% | 1.7% |
| 1Y | 6.5% | 6.3% | 4.8% |
Return vs Industry: E9Q matched the German Healthcare industry which returned 6.3% over the past year.
Return vs Market: E9Q exceeded the German Market which returned 4.8% over the past year.
Price Volatility
| E9Q volatility | |
|---|---|
| E9Q Average Weekly Movement | 10.8% |
| Healthcare Industry Average Movement | 4.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: E9Q's share price has been volatile over the past 3 months.
Volatility Over Time: E9Q's weekly volatility has decreased from 19% to 11% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 4,231 | Wangzhi Chen | www.kanghuagp.com |
Guangdong Kanghua Healthcare Group Co., Ltd., an investment holding company, primarily operates private hospitals in the People’s Republic of China. The company operates through four segments: Hospital Services, Rehabilitation and Other Healthcare Services, and Elderly Healthcare Services. It provides inpatient and outpatient healthcare, and physical examination services.
Guangdong Kanghua Healthcare Group Co., Ltd. Fundamentals Summary
| E9Q fundamental statistics | |
|---|---|
| Market cap | €88.30m |
| Earnings (TTM) | €6.44m |
| Revenue (TTM) | €258.30m |
13.7x
P/E Ratio0.3x
P/S RatioIs E9Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| E9Q income statement (TTM) | |
|---|---|
| Revenue | CN¥2.04b |
| Cost of Revenue | CN¥1.72b |
| Gross Profit | CN¥319.78m |
| Other Expenses | CN¥268.91m |
| Earnings | CN¥50.87m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 15.68% |
| Net Profit Margin | 2.49% |
| Debt/Equity Ratio | 4.8% |
How did E9Q perform over the long term?
See historical performance and comparison